null - FindTrial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2011-004232-66-FR

Enrollment

300

Registered

2011-09-20

Start date

2012-01-05

Completion date

Unknown

Last updated

2017-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Trade Name: NORADRENALINE (TARTRATE) AGUETTANT 2 mg/ml (SANS SULFITES) sol diluer p perf Product Name: norépinéphrine tartrate Pharmaceutical Form: Injection Other descriptive name: NORADRENALINE TAR

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 300 F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: ;Secondary Objective: ;Primary end point(s):	—

Countries

France

Contacts

Public ContactLacarin

CHU de Clermont-Ferrand

placarin@chu-clermontferrand.fr003304 73 751 195

Outcome results